from Reuters: Health News https://ift.tt/2LdS0Ls
Wednesday, July 18, 2018
Wednesday, July 18, 2018
MZ Digital Marketing Agency
HEALTH NEWS
No comments
AbbVie Inc said on Tuesday it signed a U.S. licensing deal with Mylan NV for its proposed biosimilar to AbbVie's blockbuster drug Humira, in a move that will give it more near-term control over the competition.

from Reuters: Health News https://ift.tt/2LdS0Ls
from Reuters: Health News https://ift.tt/2LdS0Ls
Related Posts:
LATEST HEALTH NEWS(Reuters Health) - Kids with life-threatening illnesses who receive a special gift from the Make-a-Wish Foundation may have lower hospital costs than sick children who don't get these gifts, a U.S. study suggests. from R… Read More
LATEST HEALTH NEWSAn 11th child has died in less than four weeks at a New Jersey rehabilitation center, one of 34 young patients with compromised immune systems to have been infected by a viral outbreak, state health officials said on Friday. … Read More
LATEST HEALTH NEWSFor the study, the team used data from the International Diabetes Federation and 14 cohort studies from Health https://ift.tt/2QY0NRb … Read More
LATEST HEALTH NEWSThe differences in healthy food intake were small but statistically meaningful from Health https://ift.tt/2QdQSKr … Read More
LATEST HEALTH NEWSAlphabet Inc's life sciences division Verily said on Friday that it was putting on hold one of its oldest and highest-profile projects, a smart contact lens designed to help monitor sugar levels. from Reuters: Health New… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment